MDPI and ACS Style
Gabriel, R.; Boukichou-Abdelkader, N.; Gilis-Januszewska, A.; Makrilakis, K.; Gómez-Huelgas, R.; Kamenov, Z.; Paulweber, B.; Satman, I.; Djordjevic, P.; Alkandari, A.;
et al. Reduction in the Risk of Peripheral Neuropathy and Lower Decrease in Kidney Function with Metformin, Linagliptin or Their Fixed-Dose Combination Compared to Placebo in Prediabetes: A Randomized Controlled Trial. J. Clin. Med. 2023, 12, 2035.
https://doi.org/10.3390/jcm12052035
AMA Style
Gabriel R, Boukichou-Abdelkader N, Gilis-Januszewska A, Makrilakis K, Gómez-Huelgas R, Kamenov Z, Paulweber B, Satman I, Djordjevic P, Alkandari A,
et al. Reduction in the Risk of Peripheral Neuropathy and Lower Decrease in Kidney Function with Metformin, Linagliptin or Their Fixed-Dose Combination Compared to Placebo in Prediabetes: A Randomized Controlled Trial. Journal of Clinical Medicine. 2023; 12(5):2035.
https://doi.org/10.3390/jcm12052035
Chicago/Turabian Style
Gabriel, Rafael, Nisa Boukichou-Abdelkader, Aleksandra Gilis-Januszewska, Konstantinos Makrilakis, Ricardo Gómez-Huelgas, Zdravko Kamenov, Bernhard Paulweber, Ilhan Satman, Predrag Djordjevic, Abdullah Alkandari,
and et al. 2023. "Reduction in the Risk of Peripheral Neuropathy and Lower Decrease in Kidney Function with Metformin, Linagliptin or Their Fixed-Dose Combination Compared to Placebo in Prediabetes: A Randomized Controlled Trial" Journal of Clinical Medicine 12, no. 5: 2035.
https://doi.org/10.3390/jcm12052035